These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2228022)
21. Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody. Corti A; Bagnasco L; Cassani G Lymphokine Cytokine Res; 1994 Jun; 13(3):183-90. PubMed ID: 7524695 [TBL] [Abstract][Full Text] [Related]
22. Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency. Scallon B; Cai A; Radewonuk J; Naso M Mol Immunol; 2004 May; 41(1):73-80. PubMed ID: 15140577 [TBL] [Abstract][Full Text] [Related]
24. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. Mohler KM; Torrance DS; Smith CA; Goodwin RG; Stremler KE; Fung VP; Madani H; Widmer MB J Immunol; 1993 Aug; 151(3):1548-61. PubMed ID: 8393046 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats. Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803 [TBL] [Abstract][Full Text] [Related]
26. Effects of administration of a monoclonal antibody against mouse tumor necrosis factor alpha during pregnancy and lactation on the pre- and postnatal development of the mouse immune system. Martin PL; Cornacoff JB; Treacy G; Eirikas E; Marini J; White KL; Peachee V; Hoberman A Int J Toxicol; 2008; 27(4):341-7. PubMed ID: 18821398 [TBL] [Abstract][Full Text] [Related]
27. Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells. Sakaguchi S; Furusawa S; Wu J; Nagata K Int Immunopharmacol; 2007 Feb; 7(2):191-7. PubMed ID: 17178386 [TBL] [Abstract][Full Text] [Related]
28. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Siegel SA; Shealy DJ; Nakada MT; Le J; Woulfe DS; Probert L; Kollias G; Ghrayeb J; Vilcek J; Daddona PE Cytokine; 1995 Jan; 7(1):15-25. PubMed ID: 7538333 [TBL] [Abstract][Full Text] [Related]
29. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282 [TBL] [Abstract][Full Text] [Related]
30. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288 [TBL] [Abstract][Full Text] [Related]
31. The effect of enhancing antibodies on TNF interactions with its specific receptor: consequences for in vitro TNF antiviral activity. Lidbury BA; Rathjen DA; Ramshaw IA; Cowden WB Biotechnol Ther; 1994; 5(1-2):27-45. PubMed ID: 7703831 [TBL] [Abstract][Full Text] [Related]
33. Membrane form of TNF alpha induces both cell lysis and apoptosis in susceptible target cells. Monastra G; Cabrelle A; Zambon A; Rosato A; Macino B; Collavo D; Zanovello P Cell Immunol; 1996 Jul; 171(1):102-10. PubMed ID: 8660844 [TBL] [Abstract][Full Text] [Related]
34. Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity. Koike M; Nakamura K; Furuya A; Iida A; Anazawa H; Takatsu K; Hanai N Hum Antibodies; 2009; 18(1-2):17-27. PubMed ID: 19478395 [TBL] [Abstract][Full Text] [Related]
35. Characterisation of monoclonal antibodies to human IL-4: application in an IL-4 ELISA and differential inhibition of IL-4 bioactivity on B cells and T cells. van der Pouw Kraan T; Rensink I; Aarden L Eur Cytokine Netw; 1993; 4(5):343-9. PubMed ID: 8117935 [TBL] [Abstract][Full Text] [Related]
36. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies. Margaritte C; Gilbert D; Brard F; Tron F J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030 [TBL] [Abstract][Full Text] [Related]
37. Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody. Jin H; Yang R; Marsters SA; Bunting SA; Wurm FM; Chamow SM; Ashkenazi A J Infect Dis; 1994 Nov; 170(5):1323-6. PubMed ID: 7963738 [TBL] [Abstract][Full Text] [Related]
38. Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factor. Fendly BM; Toy KJ; Creasey AA; Vitt CR; Larrick JW; Yamamoto R; Lin LS Hybridoma; 1987 Aug; 6(4):359-70. PubMed ID: 2442093 [TBL] [Abstract][Full Text] [Related]
39. Generation and characterization of a monoclonal antibody against importin α7/NPI-2. Mizuguchi C; Moriyama T; Yoneda Y Hybridoma (Larchmt); 2011 Jun; 30(3):307-9. PubMed ID: 21707368 [TBL] [Abstract][Full Text] [Related]
40. Detection and neutralization of bovine tumor necrosis factor by a monoclonal antibody. Sileghem M; Saya R; Ellis JA; Flynn JN; Peel JE; Williams DJ Hybridoma; 1992 Oct; 11(5):617-27. PubMed ID: 1459585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]